期刊文献+

低氧诱导因子-1α和p53蛋白在宫颈癌、宫颈上皮内瘤样变及正常宫颈组织中的表达及意义分析

下载PDF
导出
摘要 目的分析研讨低氧诱导因子-1α和p53蛋白在宫颈癌、宫颈上皮内瘤样变及正常宫颈组织中的表达及意义。方法随机从南方医科大学附属深圳市妇幼保健院于2015年8月—2017年10月期间收治的宫颈癌和宫颈上皮内瘤样变(CIN)患者中各抽取40例纳入到讨论中(分宫颈癌组、CIN组),并选取同时期体检健康人员40例纳入到对照组中,均接受免疫组化SP法测定p53蛋白和低氧诱导因子-1α指标,并比较分析。结果宫颈癌组、CIN组、对照组内,HIF-1α阳性率为65%、35%、0%,三者比较P<0.05;CINⅢ、CINⅡ、CIN I内HIF-1α指标比较P>0.05;宫颈癌组、CIN组、对照组内,p53阳性率为75%、42.50%、0%,三者比较P<0.05;CINⅢ、CINⅡ、CIN I内p53指标比较P>0.05。HIF-1α和p53在宫颈癌疾病临床分期和分化程度中均随着疾病恶化程度呈增长趋势,且P<0.05。结论宫颈癌发生和疾病发展中,p53和低氧诱导因子-1α过度表达发挥着重要作用,此为宫颈癌早期发病症状,指标和疾病恶性程度呈正比,低氧诱导因子-1α和宫颈癌疾病转移、发展存在关系,p53蛋白指标增高与低氧诱导因子-1α呈正比,联合检测可判定疾病恶性程度,且可预估预后和转移等。
出处 《黑龙江医学》 2018年第7期650-651,共2页 Heilongjiang Medical Journal
  • 相关文献

参考文献6

二级参考文献41

  • 1Forouzanfar MH,Foreman KJ,Delossantos AM,et al. Breast and cervical cancer in 187 countries between 1980 and 2010 : a systematic analysis [J]. Lancet, 2011,378 (9801) : 1461-1486.
  • 2Howitt BE,Nucci MR,Drapkin R,et al.Stathmin-1 ex- pression as a complement to p16 helpsidentify high-grade cervical intraepithelial neoplasia with increased specificity [J]. Am J Surg Pathol,2013,37 (1):89-97.
  • 3Lin X,Tang M,Tao Y,et al. Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle[J]. Cancer Sci,2012,103(6): 993 -999.
  • 4Miceli C,Tejada A,Castaneda A,et al. Cell cycle inhibition therapy that targets stathmin in vitro and in vivo models of breast cancer [J]. Cancer Gene Ther,2013,20(5):298-507.
  • 5Hemdan T,Lind6n MB,Lind S,et al. The prognostic value and therapeutic target roleof stathmin-1 in urinary bladder cancer [J]. Br J Cancer, 2014 , 111(6) : 1180-1187.
  • 6Nemunaitis J. Stathmin l:a protein with many tasks, new biomarker and potential target in cancer [J]. Expert Opin Ther Targets, 2012,16(7) : 631-634.
  • 7Hoekstra JW,Kummer JA,van Es RJ. Late(>5years) regional lymph node metastasis of oral squamous cell carcinoma (SCC),proven by p53 mutation analysis [J]. J Craniomax- illofac Surg, 2008,36(7) : 415-418.
  • 8Jennifer H,Dirk I., Michaela S, et al. Development of a high throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction[J]. Analytical Biochemistry,2015,468(1) :4- 14.
  • 9Boris W,Luisa F,Edward H,et al. PG545 enhances and- cancer activity of chemotherapy in ovarian models and in creases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples[J]. Europ J Cancer, 2015,51 (7) :879-892.
  • 10林亚,宋巧丽,郑飞云.野生型p53抑制宫颈癌HeLa细胞的研究[J].现代妇产科进展,2008,17(5):354-357. 被引量:4

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部